etoposide has been researched along with galactosamine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hasuike, S; Hayashi, K; Hirono, S; Hori, T; Ido, A; Moriuchi, A; Nagata, K; Nakama, T; Tsubouchi, H | 1 |
Castell, JV; Gómez-Lechón, MJ; Jover, R; O'Connor, E | 1 |
2 other study(ies) available for etoposide and galactosamine
Article | Year |
---|---|
Etoposide prevents apoptosis in mouse liver with D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure resulting in reduction of lethality.
Topics: Animals; Antigens, CD; Antineoplastic Agents, Phytogenic; Apoptosis; bcl-X Protein; Caspase 3; Caspase Inhibitors; Cytochrome c Group; Cytoplasm; Etoposide; Galactosamine; Hepatocytes; Lipopolysaccharides; Liver; Liver Failure; Male; Mice; Mice, Inbred BALB C; Proto-Oncogene Proteins c-bcl-2; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Type I; RNA, Messenger; Tumor Necrosis Factor-alpha | 2001 |
Sensitive markers used to identify compounds that trigger apoptosis in cultured hepatocytes.
Topics: Animals; Apoptosis; bcl-X Protein; Biomarkers; Camptothecin; Caspase 3; Caspases; Cells, Cultured; Curcumin; Cytochrome c Group; DNA; DNA Fragmentation; Down-Regulation; Etoposide; Flow Cytometry; Galactosamine; Hepatocytes; Male; Mitochondria; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Sensitivity and Specificity; tert-Butylhydroperoxide; Xenobiotics | 2002 |